Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial Lidocaine and Methylprednisolone for SAH Headache
NCT07054801Phase 2Recruiting
- Start
- Jun 2026
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine, methylprednisolone sodium succinate in Headache. Started Jun 2026; status: recruiting.
02
Drugs
lidocainemethylprednisolone sodium succinate
03
Conditions
Headache
Beyond the preview
Go deeper on NCT07054801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07054801.